Anavex life sciences to present at the needham virtual healthcare conference

New york, april 07, 2022 (globe newswire) -- anavex life sciences corp. (“anavex” or the “company”) (nasdaq: avxl), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including alzheimer's disease, parkinson's disease, rett syndrome and other central nervous system (cns) diseases, today announced that anavex management team will present at the 21st annual needham virtual healthcare conference on thursday, april 14, 2022, at 3:45 pm et.
AVXL Ratings Summary
AVXL Quant Ranking